Publications by authors named "Yann Fardini"

The first-line treatment for nonspecific low back pain (LBP) relief is physical exercise; however, there is no uniformity in recommendations regarding the type of exercise, and physicians predominantly prescribe pharmacological treatments. This creates a treatment gap in non-pharmacological management of LBP. Preliminary data suggest that manual therapy and acupressure could be relevant therapeutic options.

View Article and Find Full Text PDF

Human fibrinogen concentrate (Fibryga) received temporary approval for fibrinogen replacement therapy in France (2017), with subsequent full approval for congenital and acquired hypofibrinogenemia. We evaluated real-world use for on-demand treatment of bleeding and prophylaxis to enhance our knowledge on fibrinogen concentrate as an option for fibrinogen replacement. Data were retrospectively collected from adult and pediatric patients with fibrinogen deficiency.

View Article and Find Full Text PDF

Purpose: The purpose of the APRIM study (for Adherence Polyarthrite Rhumatoïde Injection Methotrexate) was to investigate the change in treatment adherence of patients with rheumatic arthritis (RA) who switched from oral to subcutaneous methotrexate (MTX).

Patients And Methods: Prospective, observational study in RA patients treated with MTX and switching from oral to subcutaneous (SC) route in real-life conditions. Data on motivations for switch, disease activity (DAS28-CRP), quality of life (AISM-2 SF), disability (HAQ-DI), and adherence to MTX were collected at inclusion (M0) and 6 months later (M6).

View Article and Find Full Text PDF
Article Synopsis
  • Immunoglobulins are used as secondary or tertiary treatments for dermatomyositis (DM) and polymyositis (PM) when corticosteroids and immunosuppressants fail, typically administered intravenously once a month or subcutaneously at home a few times a week.
  • A study involving seven patients (six with PM and one with DM) explored their experiences with both intravenous immunoglobulins (IVIg) and subcutaneous immunoglobulins (SCIg), revealing varied clinical profiles and significant improvements in symptoms after treatment.
  • Patients found SCIg to be more convenient and less disruptive to daily life compared to IVIg, allowing them to regain autonomy and control over their treatment while still being effective and well tolerated.
View Article and Find Full Text PDF

Thioredoxin interacting protein (TxNIP), which strongly responds to glucose, has emerged as a central mediator of glucotoxicity in pancreatic β cells. TxNIP is a scaffold protein interacting with target proteins to inhibit or stimulate their activity. Recent studies reported that high glucose stimulates the interaction of TxNIP with the inflammasome protein NLRP3 (NLR family, pyrin domain containing 3) to increase interleukin-1 β (IL1β) secretion by pancreatic β cells.

View Article and Find Full Text PDF
Article Synopsis
  • Immunoglobulin replacement therapy (IgRT) is used in patients with secondary immunodeficiency related to hematological malignancies to help prevent infections, and this study aimed to evaluate its effectiveness and safety.
  • In a longitudinal study in France, 160 patients with various types of hematological malignancies were observed for an average of about 8.7 months; results showed an increase in serum immunoglobulin levels and a reduction in infection frequency and severity.
  • The study highlighted a diverse range of treatment adherence and management practices among patients, with 38% continuing IgRT without interruption while others had varying degrees of treatment discontinuation.
View Article and Find Full Text PDF

Purpose: Subcutaneous immunoglobulin replacement therapy (IgRT) may be administered once a week with a pump or every other day with a syringe (rapid push). The objective of the study was to compare the impact of pump and rapid push infusions on patient's life quality index (LQI).

Methods: This study was a randomized, crossover, multicenter, non-inferiority trial conducted in adults with primary immunodeficiency (PID) accustomed to weekly infusions at home by pump.

View Article and Find Full Text PDF
Article Synopsis
  • The study aimed to outline the characteristics of patients with secondary immunodeficiencies associated with hematological malignancies who began immunoglobulin replacement therapy (IgRT) and examine physicians' expectations regarding this treatment.
  • It involved 231 patients mostly suffering from conditions like multiple myeloma and chronic lymphoid leukemia, with a significant portion experiencing recurrent infections and low serum immunoglobulin levels.
  • Physicians anticipated that IgRT would prevent infections, improve patients' quality of life, and potentially enhance survival, even considering prophylactic treatment without a prior infection history.
View Article and Find Full Text PDF
Article Synopsis
  • - Patients with primary immunodeficiency (PID) often receive immunoglobulin replacement therapy (IgRT) via methods like subcutaneous infusions using either an automated pump (P) or manual syringe push (RP), with P being less frequent but longer in duration compared to the more frequent but quicker RP infusions.
  • - A study involving interviews with PID patients revealed that while RP is slightly more cost-effective and has similar efficacy to P, many patients preferred P due to better integration into their daily routine and less frequent reminders of their disease.
  • - The focus group indicated that the complexity of living with PID influences their delivery method preference, as patients found RP cumbersome and not necessarily time-saving, suggesting that healthcare providers should explore these personal experiences further
View Article and Find Full Text PDF

The viral Tax oncoprotein plays a key role in both Human T-cell lymphotropic virus type 1 (HTLV-1)-replication and HTLV-1-associated pathologies, notably adult T-cell leukemia. Tax governs the transcription from the viral 5'LTR, enhancing thereby its own expression, via the recruitment of dimers of phosphorylated CREB to cAMP-response elements located within the U3 region (vCRE). In addition to phosphorylation, CREB is also the target of O-GlcNAcylation, another reversible post-translational modification involved in a wide range of diseases, including cancers.

View Article and Find Full Text PDF

Context: Insulin analogues are largely used for the treatment of diabetic patients, but concerns have been raised about their mitogenic/anti-apoptotic potential. It is therefore important to evaluate these analogues in different cell systems.

Objective: The aim of this work was to establish the pharmacological profiles of insulin analogues towards PI-3 kinase/Akt pathway in INS-1 β-pancreatic cells.

View Article and Find Full Text PDF

O-GlcNAcylation is a reversible post-translational modification that regulates cytosolic and nuclear proteins. We and others previously demonstrated that FoxO1 is O-GlcNAcylated in different cell types, resulting in an increase in its transcriptional activity. Four O-GlcNAcylation sites were identified in human FOXO1 but directed mutagenesis of each site individually had modest (T317) or no effect (S550, T648, S654) on its O-GlcNAcylation status and transcriptional activity.

View Article and Find Full Text PDF

O-GlcNAcylation on serine/threonine is a post-translational modification that controls the activity of nucleocytoplasmic proteins according to glucose availability. We previously showed that O-GlcNAcylation of FoxO1 in liver cells increases its transcriptional activity. In the present study, we evaluated the potential involvement of FoxO1 O-GlcNAcylation in the context of pancreatic β-cell glucotoxicity.

View Article and Find Full Text PDF

O-linked N-acetylglucosaminylation (O-GlcNAcylation) is a reversible post-translational modification consisting in the addition of a sugar moiety to serine/threonine residues of cytosolic or nuclear proteins. Catalyzed by O-GlcNAc-transferase (OGT) and removed by O-GlcNAcase, this dynamic modification is dependent on environmental glucose concentration. O-GlcNAcylation regulates the activities of a wide panel of proteins involved in almost all aspects of cell biology.

View Article and Find Full Text PDF

O-GlcNAcylation (addition of N-acetyl-glucosamine on serine or threonine residues) is a post-translational modification that regulates stability, activity or localization of cytosolic and nuclear proteins. O-linked N-acetylgluocosmaine transferase (OGT) uses UDP-GlcNAc, produced in the hexosamine biosynthetic pathway to O-GlcNacylate proteins. Removal of O-GlcNAc from proteins is catalyzed by the β-N-Acetylglucosaminidase (OGA).

View Article and Find Full Text PDF

The folding and insertion of β-barrel proteins in the outer membrane of Gram-negative bacteria is mediated by the BAM complex, which is composed of the outer membrane protein BamA and four lipoproteins BamB to BamE. In Escherichia coli and/or Salmonella, the BamB lipoprotein is involved in (i) β-barrel protein assembly in the outer membrane, (ii) outer membrane permeability to antibiotics, (iii) the control of the expression of T3SS which are major virulence factors and (iv) the virulence of Salmonella. In E.

View Article and Find Full Text PDF

Fusobacterium nucleatum is a Gram-negative oral anaerobe, capable of systemic dissemination causing infections and abscesses, often in mixed-species, at different body sites. We have shown previously that F. nucleatum adheres to and invades host epithelial and endothelial cells via a novel FadA adhesin.

View Article and Find Full Text PDF

Background: Intrauterine infection is a recognized cause of adverse pregnancy outcome, but the source of infection is often undetermined. We report a case of stillbirth caused by Fusobacterium nucleatum that originated in the mother's mouth.

Case: A woman with pregnancy-associated gingivitis experienced an upper respiratory tract infection at term, followed by stillbirth a few days later.

View Article and Find Full Text PDF

Microbial infection of the intrauterine environment is a major cause of preterm birth. The current paradigm indicates that intrauterine infections predominantly originate from the vaginal tract, with the organisms ascending into the sterile uterus. With the improvements in technology, an increasing number of bacterial species have been identified in intrauterine infections that do not belong to the vaginal microflora.

View Article and Find Full Text PDF
Article Synopsis
  • The assembly of outer-membrane proteins in Salmonella relies on the BAM complex and periplasmic chaperones, highlighting the importance of specific proteins like BamD, BamB, and SurA.
  • Deletion mutants demonstrated that while BamD is critical for type-III secretion system (T3SS-1) expression and flagella, it is not essential for outer-membrane integrity, unlike in E. coli.
  • The study indicated no general relationship between outer-membrane protein assembly defects and downregulation of T3SSs, suggesting a more specific mechanism mainly involving BamB and BamD.
View Article and Find Full Text PDF

Since the 1990s, Brucella strains have been isolated from a wide variety of marine mammals and were recently recognized as two different species, i.e. Brucella pinnipedialis for pinniped isolates and Brucella ceti for cetacean isolates.

View Article and Find Full Text PDF

Salmonella enterica, like many gram-negative pathogens, uses type three secretion systems (TTSS) to infect its hosts. The three TTSS of Salmonella, namely, TTSS-1, TTSS-2, and flagella, play a major role in the virulence of this bacterium, allowing it to cross the intestinal barrier and to disseminate systemically. Previous data from our laboratory have demonstrated the involvement of the chromosomal region harboring the yfgL, engA, and yfgJ open reading frames in S.

View Article and Find Full Text PDF